|
1. Abuyassin B, Laher I. Obesity-linked diabetes in the Arab world: a review. East Mediterr Health J. 2015 Sep;21(6):420-39. 2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 May; 27(5):1047-53. 3. Chalmers J, Joshi R, Patel A. Advances in reducing the burden of vascular disease in type 2 diabetes. Clin Exp Pharmacol Physiol. 2008 Apr; 35(4): 434-7. doi:10.1111/j.1440-1681.2008.04892.x 4. Manrique C, Sowers JR. Insulin resistance and skeletal muscle vasculature: significance, assessment and therapeuticmodulators. Cardiorenal Med. 2014 Dec; 4(3-4): 244-56. doi:10.1159/000368423 5. Eleftheriou P, Tseka E, Varaga E, Nasiou M, Sampanis C, Zografou I, et al. Study of the lipidemic profile of diabetic patients. Negative correlation of cholesterol levels of diabetestype I patients with serum amylase concentration. Hell J Nucl Med. 2014 Jan-Apr; 17 (Suppl 1): 35-9. 6. Hogan P, Dall T, Nikolov P; American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003 Mar; 26(3): 917-32. 7. López-Jaramillo P, Velandia-Carrillo C, Gómez-Arbeláez D1, Aldana-Campos M. Is the present cut-point to define type 2 diabetes appropriate in Latin-Americans? World J Diabetes. 2014 Dec; 5(6): 747-55. doi:10.4239/wjd.v5.i6.747 8. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006 Apr; 6(4): 259-69. doi:10.1038/nrc1840 9. Balasubramanyam M, Aravind S, Gokulakrishnan K, Prabu P, Sathishkumar C, Ranjani H, et al. Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes. Mol Cell Biochem. 2011 May; 351(1-2): 197-205. doi:10.1007/s11010-011-0727-3 10. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 2008 Feb; 451(7182): 1125-9. doi:10.1038/nature06607 11. Zheng RL, Jiang YJ, Wang X. Role of microRNAs on therapy resistance in Non-Hodgkin's lymphoma. Int J Clin Exp Med. 2014 Nov; 7(11): 3818-32. 12. Esquela-Kerscher A, Slack FJ. Oncomirs – microRNAs with a role in cancer. Nat Rev Cancer. 2006 Apr; 6(4): 259-69. doi:10.1038/nrc1840 13. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setién F, et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 2007 Feb; 67(4): 1424-9. doi:10.1158/0008-5472.CAN-06-4218 14. Krichevsky AM, Sonntag KC, Isacson O, Kosik KS. Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells. 2006 Apr;24(4):857-64. doi:10.1634/stemcells.2005-0441 15. Conaco C, Otto S, Han JJ, Mandel G. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2422-7. doi:10.1073/pnas.0511041103 16. Baroukh N, Ravier MA, Loder MK, Hill EV, Bounacer A, Scharfmann R, et al. MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines. J Biol Chem. 2007 Jul; 282(27): 19575-88. doi:10.1074/jbc.M611841200 17. Zhao X, Ye Q, Xu K, Cheng J, Gao Y, Li Q, et al. Single-nucleotide polymorphisms inside microRNA target sites influence the susceptibility to type 2diabetes. J Hum Genet. 2013 Mar; 58(3): 135-41. doi:10.1038/jhg.2012.146 18. Gong W, Xiao D, Ming G, Yin J, Zhou H, Liu Z. Type 2 diabetes mellitus-related genetic polymorphisms in microRNAs and microRNA target sites. J Diabetes. 2014 Jul; 6(4): 279-89. doi:10.1111/1753-0407.12143 19. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004 Nov; 432(7014): 226-30. doi:10.1038/nature03076 20. Li Y, Xu X, Liang Y, Liu S, Xiao H, Li F, et al. miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressingmyotrophin (V1) protein expression. Int J Clin Exp Pathol. 2010 Jan; 3(3): 254-64. 21. Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, Regazzi R. MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J Biol Chem. 2006 Sep; 281(37): 26932-42. doi:10.1074/jbc.M601225200 22. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, et al. Combinatorial microRNA target predictions. Nat Genet. 2005 May; 37(5): 495-500. doi:10.1038/ng1536 23. Qi L, Hu Y, Zhan Y, Wang J, Wang BB, Xia HF, et al. A SNP site in pri-miR-124 changes mature miR-124 expression but no contribution to Alzheimer'sdisease in a Mongolian population. Neurosci Lett. 2012 Apr; 515(1): 1-6. doi:10.1016/j.neulet.2012.02.061 24. Bartoli E, Fra GP, Carnevale Schianca GP. The oral glucose tolerance test (OGTT) revisited. Eur J Intern Med. 2011 Feb; 22(1): 8-12. doi:10.1016/j.ejim.2010.07.008 25. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb; 16(3): 1215. 26. Ciccacci C, Di Fusco D, Cacciotti L, Morganti R, D'Amato C, Greco C, et al. MicroRNA genetic variations: association with type 2 diabetes. Acta Diabetol. 2013 Dec; 50(6): 867-72. doi:10.1007/s00592-013-0469-7 27. Polina ER, Sbruzzi RC, Silva MEDC, Canani LH, Crispim D, Santos KGD. Relationship of polymorphisms in microRNAs -124 e -126 with diabetic retinopathy in patients with type 2 diabetes. Diabetol Metab Syndr. 2015; 7(Suppl 1): A214. doi:10.1186/1758-5996-7-S1-A214 28. Wang TT, Chen YJ, Sun LL, Zhang SJ, Zhou ZY, Qiao H. Affection of single-nucleotide polymorphisms in miR-27a, miR-124a, and miR-146a on susceptibility to type 2 diabetes mellitus in Chinese Han people. Chin Med J (Engl). 2015 Feb; 128(4): 533-9. doi:10.4103/0366-6999.151112
|
